Evidence map›Paper›PMID 38648857›Full record

ArticleMedical physics2024

AAPM Task Group 334: A guidance document to using radiotherapy immobilization devices and accessories in an MR environment.

Maritza A Hobson, Yanle Hu, Barrett Caldwell, Gil'ad N Cohen, Carri Glide-Hurst, Long Huang, Paul D Jackson, Sunyoung Jang, Ulrich Langner, Hannah J Lee and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maritza A HobsonDepartment of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Yanle HuDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Barrett CaldwellSchool of Industrial Engineering, Purdue University, West Lafayette, Indiana, USA.
Gil'ad N CohenDepartment of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Carri Glide-HurstDepartment of Human Oncology, University of Wisconsin--Madison, Madison, Wisconsin, USA.
Long HuangDepartment of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA.
Paul D JacksonDepartment of Radiation Oncology, Henry Ford Health System, Detroit, Michigan, USA.
Sunyoung JangDepartment of Radiation Oncology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Ulrich LangnerDepartment of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island, USA.
Hannah J LeeCorewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
Ives R LevesqueGerald Bronfman Department of Oncology and Medical Physics Unit, McGill University, Montreal, QC, Canada.
Sreeram NarayananDepartment of Radiation Oncology, Virginia Mason Cancer Institute, Seattle, Washington, USA.
Justin C ParkDivision of Medical Physics, Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
John SteffenCQ Medical, Coralville, Iowa, USA.
Q Jackie WuDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.
Yong ZhouDepartment of Radiology Services, Corewell Health, Grand Rapids, Michigan, USA.

Funding

Reducing cardiac toxicity with deep learning and MRI-guided radiation therapyR01HL153720 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GLIDE-HURST, CARRI KAYE · 2021 to 2024
$2.2M
Development of Anatomical Patient Models to Facilitate MR-only Treatment PlanningR01CA204189 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GLIDE-HURST, CARRI KAYE · 2016 to 2020
$1.5M
NCI NIH HHS R01 CA204189NHLBI NIH HHS R01 HL153720
6 · The paper itself

Abstract

Use of magnetic resonance (MR) imaging in radiation therapy has increased substantially in recent years as more radiotherapy centers are having MR simulators installed, requesting more time on clinical diagnostic MR systems, or even treating with combination MR linear accelerator (MR-linac) systems. With this increased use, to ensure the most accurate integration of images into radiotherapy (RT), RT immobilization devices and accessories must be able to be used safely in the MR environment and produce minimal perturbations. The determination of the safety profile and considerations often falls to the medical physicist or other support staff members who at a minimum should be a Level 2 personnel as per the ACR. The purpose of this guidance document will be to help guide the user in making determinations on MR Safety labeling (i.e., MR Safe, Conditional, or Unsafe) including standard testing, and verification of image quality, when using RT immobilization devices and accessories in an MR environment.

Indexed as

ImmobilizationMagnetic Resonance ImagingHumansRadiotherapy, Image-Guidedimmobilization devicesmagnetic resonanceMR Safetyradiotherapy

Identifiers

PMID38648857
PMCPMC11330642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.